Fig. 6From: Integrative analysis of m3C associated genes reveals METTL2A as a potential oncogene in breast CancerRelationship between METTL2A expression and clinicopathological parameters in BRCA. Distribution of METTL2A expression stratified by a, b Grade, c T stage, d HER2 status, e ER status, and f P53 mutation status. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001Back to article page